What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

dc.contributor.author	Czobor, Pál
dc.contributor.author	Sebe, Barbara
dc.contributor.author	Acsai, Károly
dc.contributor.author	Barabássy, Ágota
dc.contributor.author	Laszlovszky, István
dc.contributor.author	Németh, György
dc.contributor.author	Furukawa, Toshi A.
dc.contributor.author	Leucht, Stefan
dc.date.accessioned	2022-05-09T07:13:35Z
dc.date.available	2022-05-09T07:13:35Z
dc.date.issued	2022
dc.identifier.citation	journalVolume=13;pagination=816339, pages: 9;journalTitle=FRONTIERS IN PSYCHIATRY;journalAbbreviatedTitle=FRONT PSYCHIATRY;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/9050
dc.identifier.uri	doi:10.3389/fpsyt.2022.816339
dc.relation.ispartof	urn:issn:1664-0640; 1664-0640
dc.title	What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial
dc.type	Journal Article
dc.date.updated	2022-05-06T08:41:38Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	32808326
dc.contributor.department	SE/AOK/K/Pszichiátriai és Pszichoterápiás Klinika
dc.contributor.institution	Semmelweis egyetem